Stroke Clinical Trials

Active Studies: Acute Stroke Active Studies: Secondary Stroke Prevention Stroke Rehabilitation Pending Studies
  • RELIEF
    Condition studied: migraine, patent foramen ovale (PFO)
Closed Studies

 

 


 

AXIOMATIC-BMS

A Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Response-Adaptive Dose-Ranging Study of BMS-986177, an Oral Factor XIa Inhibitor, for the Prevention of New Ischemic Stroke or New Covert Brain Infarction in Patients Receiving Aspirin and Clopidogrel Following Acute Ischemic Stroke or Transient Ischemic Attack (TIA).
  • Study director (local PI): David Chiu, MD
  • Condition studied: acute ischemic stroke, transient ischemic attack (TIA)
  • ClinicalTrials.gov identifier: NCT03766581
  • IRB #: Pro00022059
  • IRB approval date: 08/22/2019
  • To learn more email David McCane at dmccane@houstonmethodist.org or call 713.441.5801

 

Top of page

 

 

 


 

MASTERS-2- Athersys

Multistem® Administration for Stroke Treatment and Enhanced Recovery Study. A Phase 3, randomized, double-blind, placebo-controlled, multicenter international study.

 

Top of page

 

 

 


 

MOST Trial NIH/StrokeNET

Multi-arm Optimization of Stroke Thrombolysis (MOST): a blinded, randomized controlled adaptive, multi-arm, adjunctive-thrombolysis efficacy trial in ischemic stroke. Determine if argatroban or eptifibatide results in improved 90-day mRS as compared with placebo in acute ischemic stroke patients treated with IV rt-PA within three hours of symptom onset. Patients may also receive endovascular thrombectomy (ET) per usual care.

 

Top of page

 

 

 


 

REDUCE PAS

Gore Cardioform Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patient Foramen Ovale (PFO): the REDUCE Post Approval Study.
  • Study director (National PI): John J. Volpi, MD
  • Study director (Local PI): Chun H. Lin, MD
  • Condition studied: ischemic stroke, patent foramen ovale (PFO)
  • ClinicalTrials.gov Identifier: NCT03821129
  • IRB #: Pro00021260
  • IRB approval date: 09/24/2019
  • To learn more email Amber Criswell at acriswell@houstonmethodist.org or call 346.238.5214.

 

Top of page

 

 

 


 

SORT - Stroke and Artificial Intelligence (SORT) Screening Study

This is a prospective screening study aimed to develop a rapid screening tool and artificial intelligence software to assist clinicians during triage for stroke. The study is actively enrolling both healthy volunteers and patients.
  • Study director (National PI): John J. Volpi, MD
  • Condition studied: acute neurological symptoms, acute stroke, chronic stroke
  • ClinicalTrials.gov Identifier: (None, not listed)
  • IRB #: Pro00020577
  • IRB approval date: 11/15/2018
  • To learn more email Amber Criswell at acriswell@houstonmethodist.org or call 346.238.5214.

 

Top of page

 

 

 


 

ARCADIA-NIH/StrokeNET


AtRial Cardiopathy and Antithrombotic Drugs in Prevention After cryptogenic stroke.
  • Study director (local PI): Vivek Misra, MD
  • Condition studied: ischemic stroke
  • ClinicalTrials.gov Identifier: NCT03192215
  • IRB #: Pro00019940
  • IRB approval date: 07/06/2018  
  • Contact info: To learn more email David McCane at dmccane@houstonmethodist.org or call 713.441.5801

 

Top of page

 

 

 


 

BUBL- Robotic TCD Ultrasound Bubble Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt

Multi-center, prospective, single-arm, non-significant risk (NSR) device study in 150 patients with suspicion of embolic stroke of undetermined source.

  • Study director (National PI): John J. Volpi, MD
  • Condition treated: embolic stroke of undetermined source (ESUS), transient ischemic attack (TIA), right-to-left atrial shunt, patent foramen ovale (PFO)
  • ClinicalTrials.gov Identifier: NCT04604015
  • IRB #: Pro00026775
  • IRB approval date: 11/10/2020
  • To learn more email Amber Criswell at acriswell@houstonmethodist.org or call 346.238.5214.

 

Top of page

 

 

 


 

CREST-2 NIH/StrokeNET 

Carotid Revascularization for Primary Prevention of Stroke.

 

Top of page

 

 

 


 

Music Listening in Stroke Recovery

Music listening or spoken word listening for patients with following a 90-day listening schedule for patients with recent stroke within 30days to 1 year. 

 

Top of page

 

 

 


 

RELIEF

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study: A Study to evaluate the safety and efficacy of transcatheter closure of patent foramen ovale for relief of migraine headaches. Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the Gore Cardioform Septal Occluder for migraine headache relief.
  • Study direction (Local PI): Chun H. Lin, MD
  • Condition studied: migraine, patent foramen ovale (PFO)
  • ClinicalTrials.gov Identifier: NCT04100135
  • IRB #: Pro00024894
  • IRB approval date: 09/08/2020
  • To learn more email Amber Criswell at acriswell@houstonmethodist.org or call 346.238.5214.

 

Top of page

 

 

Top of page